DISCLAIMER: FOR RESEARCH USE ONLY. The material provided is "as is", and using TOPOGRAPH is without warranties of any kind, either expressed or implied. The content provided by this resource CANNOT substitute for clinical judgement or professional oncology advice. Improper use of this resource may lead to harm.

NOTE: The haematology contents of this resource is currently under review and in the process of being updated.

Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20260610 (AU)

273
Gene and protein biomarkers

79
Combination biomarkers

14
Complex biomarkers

1246
Simple mutations

480
Variant groups

191
Protein expressions

185
Amplification deletions

358
Fusions and Rearrangements

5
Splice variants

8
Methylations

27
Germline mutations

48
Common cancers

82
T1

91
T2

181
T3

304
T4

10
R1

182
R2

25
Less common cancers

19
T1

14
T2

49
T3

114
T4

0
R1

22
R2

187
Rare cancers

39
T1

47
T2

137
T3

389
T4

6
R1

154
R2

© 2020-2026, Garvan Institute of Medical Research, University of Sydney, and Omico
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.